Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-849
Closed -$68.9K 696
2023
Q1
$68.9K Buy
849
+786
+1,248% +$63K 0.01% 525
2022
Q4
$4.7K Sell
63
-309
-83% -$24K ﹤0.01% 1195
2022
Q3
$31K Buy
372
+347
+1,388% +$30.4K ﹤0.01% 701
2022
Q2
$2K Sell
25
-46
-65% -$4.66K ﹤0.01% 1150
2022
Q1
$8K Buy
71
+35
+97% +$3.93K ﹤0.01% 929
2021
Q4
$4K Buy
36
+27
+300% +$2.9K ﹤0.01% 1043
2021
Q3
$1K Buy
9
+2
+29% +$250 ﹤0.01% 1251
2021
Q2
$1K Hold
7
﹤0.01% 1139
2021
Q1
$1K Hold
7
﹤0.01% 1139
2020
Q4
$1K Hold
7
﹤0.01% 1048
2020
Q3
$1K Hold
7
﹤0.01% 990
2020
Q2
$1K Sell
7
-11
-61% -$859 ﹤0.01% 984
2020
Q1
$1K Buy
18
+3
+20% +$236 ﹤0.01% 867
2019
Q4
$1K Buy
+15
New +$995 ﹤0.01% 760

Other funds holding DVA

Ellevest Inc's DVA Position: Q2 2023 in Review

Ellevest Inc sold out of DaVita (DVA) in Q2 2023, closing a stake of 849 shares — an estimated $68.9K sold.

Ellevest Inc first reported a position in DVA in Q4 2019 and held it in 14 quarters. The position peaked at $68.9K in Q1 2023. 471 funds tracked by Wall St. Rank hold DVA as of Q2 2023.

  • Ellevest Inc reported no remaining DaVita position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 849 DaVita shares in Q2 2023, an estimated $68.9K.
  • Ellevest Inc first reported a position in DaVita in Q4 2019 and held it in 14 quarters.
  • Ellevest Inc's DaVita position peaked at $68.9K in Q1 2023.
  • 471 funds tracked by Wall St. Rank held DaVita as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.